1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. UNITED STATES AI IN PRECISION THERAPIES MARKET BY THERAPY TYPE
5.1. Introduction
5.2. Personalized Medicine
5.3. Targeted Therapies
5.4. Gene Therapies
5.5. Cell Therapies
5.6. Immunotherapies
5.7. Others
6. UNITED STATES AI IN PRECISION THERAPIES MARKET BY APPLICATION
6.1. Introduction
6.2. Oncology
6.3. Neurology
6.4. Cardiology
6.5. Infectious Diseases
6.6. Rare Diseases
6.7. Autoimmune Diseases
6.8. Others
7. UNITED STATES AI IN PRECISION THERAPIES MARKET BY END-USERS
7.1. Introduction
7.2. Hospitals And Clinics
7.3. Pharmaceutical And Biotechnology Companies
7.4. Research Institutes And Academic Centers
7.5. Others
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Competitive Dashboard
9. COMPANY PROFILES
9.1. IBM Watson Health (IBM Corporation)
9.2. Google Health (Alphabet Inc.)
9.3. Tempus Labs, Inc.
9.4. Nvidia Corporation
9.5. Deep Genomics, Inc.
9.6. Microsoft Corporation
9.7. Owkin, Inc.
9.8. Benevolentai Ltd.
9.9. Recursion Pharmaceuticals, Inc.
9.10. Cloud Pharmaceuticals, Inc.
10. APPENDIX
10.1. Currency
10.2. Assumptions
10.3. Base and Forecast Years Timeline
10.4. Key benefits for the stakeholders
10.5. Research Methodology
10.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES